ArticleExperimental & molecular medicine2025

Dihydroartemisinin inhibits metastatic potential and cancer stemness by modulating the miR-200b-BMI-1/VEGF-A axis in ovarian cancer.

Jin Gu Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.